.Nature Medication, Released online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medication conjugate (ADC) tisotumab vedotin resulted in enhanced progression-free and total survival, triggering FDA approval and also a brand-new therapy option for individuals.